Roswell Park Cancer Institute: Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

The registry lists 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies with Roswell Park Cancer Institute as lead sponsor. 2 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 5No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• MedSupport Intervention to Identify and Address Barriers to Pediatric Medication AdherenceRecruitingNCT06323044Not applicable
• Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3RecruitingNCT06074666Not applicable
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerTerminatedNCT03333486Phase 2Results posted
• Rasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesTerminatedNCT01564277Phase 2Results posted
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01529827Phase 2Results posted
• Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersCompletedNCT00856388Not applicableResults posted
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
• Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication AdherenceCompletedNCT05587582
• Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic LeukemiaWithdrawnNCT03851081Phase 1/2
• Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00053131Phase 2
• Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic LeukemiaCompletedNCT00022035Not applicable